210 related articles for article (PubMed ID: 11002254)
1. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
[TBL] [Abstract][Full Text] [Related]
3. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
Fassone L; Cingolani A; Martini M; Migliaretti G; Oreste PL; Capello D; Gloghini A; Vivenza D; Dolcetti R; Carbone A; Antinori A; Gaidano G; Larocca LM
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):19-26. PubMed ID: 11804553
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
7. Deletions and single-base mutations within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of southern Japan.
Mori S; Itoh T; Tokunaga M; Eizuru Y
J Med Virol; 1999 Feb; 57(2):152-8. PubMed ID: 9892400
[TBL] [Abstract][Full Text] [Related]
8. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease.
Schuster V; Seidenspinner S; Kreth HW
J Med Virol; 1996 Jan; 48(1):114-20. PubMed ID: 8825720
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
[TBL] [Abstract][Full Text] [Related]
11. No significant association of Epstein-Barr virus infection with invasive breast carcinoma.
Chu PG; Chang KL; Chen YY; Chen WG; Weiss LM
Am J Pathol; 2001 Aug; 159(2):571-8. PubMed ID: 11485915
[TBL] [Abstract][Full Text] [Related]
12. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD
J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808
[TBL] [Abstract][Full Text] [Related]
13. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
Hirose Y; Masaki Y; Kurose N
Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
[TBL] [Abstract][Full Text] [Related]
14. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
[TBL] [Abstract][Full Text] [Related]
16. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
17. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
Herbst H; Dallenbach F; Hummel M; Niedobitek G; Finn T; Young LS; Rowe M; Müller-Lantzsch N; Stein H
Blood; 1991 Nov; 78(10):2666-73. PubMed ID: 1668608
[TBL] [Abstract][Full Text] [Related]
19. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
[TBL] [Abstract][Full Text] [Related]
20. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
